Is Generative AI Changing the Game for Medtech?

Perspectives Unlocking new dimensions of efficiency and innovation Dive into the transformative impacts of artificial intelligence (AI) and Generative Artificial Intelligence (GenAI) in the evolving medtech landscape. Our report takes an in-depth look at how these technologies are reshaping the industry, delivering value, and setting the stage for further advancements. Tapping into value to get ahead of medtech competition Across industries, AI and GenAI discussions are moving from potential to value realization. For medtech companies, this value can be in the form of cost efficiencies and new revenue generation.To assess where medtech companies have realized value from AI and GenAI and what could be next, the Deloitte Center for Health Solutions surveyed 85 leaders from medtech organizations during the summer of 2024 and conducted follow-up interviews. We found that:AI and GenAI have begun to deliver value across functions, with 42% of surveyed executives reporting benefits in product...